A shocking revelation about drug pricing has exposed yet another example of the American healthcare system’s bloated costs, and taxpayers are the ones footing the bill.
A small pharmacy owner in Georgia revealed that Medicare is paying an outrageous $2,400 for a vital cancer drug, while his business can sell the same medication for just $17. The stark difference in pricing has fueled fresh scrutiny over pharmacy benefit managers (PBMs) and their role in skyrocketing healthcare expenses.
WARNING: 3 Highly Toxic Ingredients in Your Food
Brad Hart, who owns Forest Park Pharmacy, recently took to social media to share the astonishing price disparity for imatinib, a life-saving leukemia treatment also known as Gleevec. He explained that his pharmacy can acquire the drug for just $7, and after a small markup, patients pay a mere $17.
>> Click Here To Continue Reading <<
